The DEA Allows Unlikely Candidate to Import Cannabis Internationally

Warning message

The subscription service is currently unavailable. Please try again later.

The complex politics of cannabis make for some very strange bedfellows, and the latest case is no exception. The United States Drug Enforcement Administration approved the New Jersey-based organization Catalent to receive imported cannabis for research purposes.

Catalent Pharma Solutions, which is classified as a Contract Development and Manufacturing Organization (CDMO), is based out of Somerset, New Jersey, but the site it registered with the DEA is in Kansas City, Missouri. The Federal Notice released by the Administration states:

“The DEA has…determined that the registration of Catalent CTS, LLC to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971.”

Catalent’s Kansas City site is just one of 31 locations to provide specialized production, storage, and logistics capabilities for controlled substances to support clinical trials and distribution...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.